Pharmaceuticals
Healthcare
How did Quadria Capital fare in exit from six-year-old India portfolio company?
Healthcare-focused private equity firm Quadria Capital, which made the final close of its third fund with $1.07 billion (around Rs ......
Healthcare
Eight Roads-backed PlasmaGen Bio snags funding, valuation nears $170 mn
PlasmaGen Biosciences, a biopharmaceutical company which counts investors such as Eight Roads Ventures in its captable, has raised capital from ......
Healthcare
API maker SCL Lifesciences eyes maiden PE cheque, hires banker
Hyderabad-based pharmaceutical manufacturer SCL Lifesciences Ltd (formerly Saurav Chemicals) is eyeing its maiden round of external funding, at least two people ......
Healthcare
ChrysCapital-backed Intas Pharma strikes another overseas acquisition
Gujarat-based drugmaker Intas Pharmaceuticals Ltd., which counts private equity firm ChrysCapital, Singapore state investment firm Temasek and Abu Dhabi Investment ......
Healthcare
TA Associates-backed OmniActive Health acquires botanical drugs maker
Integrated nutraceutical ingredient manufacturer OmniActive Health Technologies Ltd, which is backed by the US-based private equity firm TA Associates, said ......
Healthcare
PE-backed pharma companies Sai Life and Rubicon Research get nod for IPO
Two homegrown healthcare companies, backed by private equity firms General Atlantic and TPG, have received approval from capital markets regulator ......
Healthcare
Symbiotec eyes IPO to give exit to PE investors; can it command a high valuation?
Bulk drug maker Symbiotec Pharmalab is planning to explore the possibility of floating an initial public offering in the next ......
Healthcare
India SME Investments makes second bet from latest fund
India SME Investments, a private equity firm that is currently in the process of raising its second fund, has made ......
Healthcare
Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask
Private equity giant KKR is considering a new multi-billion dollar plan to monetise its four-year-old bet on JB Chemicals & ......
Healthcare
What are Carlyle-backed Sequent Scientific's plans after recent merger announcement?
Private equity firm Carlyle-controlled SeQuent Scientific Ltd. aims to establish a larger platform focussed on pure-play animal health portfolio following ......